Arkolith/Insider Trading/SGMT/Form 4

Happel David

President & CEO, DirectorSagimet Biosciences Inc. (SGMT) · full profile →Form 4 · filed Jul 23, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$598K
Net Open-Market Flow
-$598K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 21, 2025Sell(S)65K$9.13$598K690K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-070017) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML